Kinetic study of photocatalytic degradation of carbamazepine, clofibric acid, iomeprol and iopromide assisted by different TiO2 materials--determination of intermediates and reaction pathways.
The light-induced degradation of clofibric acid, carbamazepine, iomeprol and iopromide under simulated solar irradiation has been investigated in aqueous solutions suspended with different TiO2 materials (P25 and Hombikat UV100). Kinetic studies showed that P25 had a better photocatalytic activity for clofibric acid and carbamazepine than Hombikat UV100. For photocatalytic degradation of iomeprol Hombikat UV100 was more suitable than P25. The results can be explained by the higher adsorption capacity of Hombikat UV100 for iomeprol. The study also focuses on the identification and quantification of possible degradation products. The degradation process was monitored by determination of sum parameters and inorganic ions. In case of clofibric acid various aromatic and aliphatic degradation products have been identified and quantified. A possible multi-step degradation scheme for clofibric acid is proposed. This study proves the high potential of the photocatalytic oxidation process to transform and mineralize environmentally relevant pharmaceuticals and contrast media in water.
Doll
Tusnelda E
TE
Water Chemistry, Engler-Bunte-Institut, Universität Karlsruhe, Engler-Bunte-Ring 1, Karlsruhe 76131, Germany.
Frimmel
Fritz H
FH
D000327:Adsorption; D000927:Anticonvulsants / Q000737:chemistry*; D002220:Carbamazepine / Q000737:chemistry*; D002384:Catalysis; D002995:Clofibric Acid / Q000737:chemistry*; D004396:Coloring Agents / Q000737:chemistry*; D003287:Contrast Media / Q000737:chemistry*; D000960:Hypolipidemic Agents / Q000737:chemistry*; D007472:Iohexol / Q000031:analogs & derivatives* / Q000737:chemistry*; D007479:Iopamidol / Q000031:analogs & derivatives* / Q000737:chemistry*; D007700:Kinetics; D010084:Oxidation-Reduction; D010777:Photochemistry; D014025:Titanium / Q000737:chemistry*
D000927:Anticonvulsants; D004396:Coloring Agents; D003287:Contrast Media; D000960:Hypolipidemic Agents; C009495:titanium dioxide; C057937:iomeprol; D002220:Carbamazepine; D007472:Iohexol; D002995:Clofibric Acid; C038192:iopromide; D014025:Titanium; D007479:Iopamidol